• Santhera submits MAA to EMA for Puldysa pharmatimes
    May 28, 2019
    Santhera Pharmaceuticals has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Puldysa (idebenone) in duchenne muscular dystrophy.
PharmaSources Customer Service